Please note that assistive links (commonly known as "skip to links") are used throughout this site. These links are not well-supported by some mobile devices. If you are encountering difficulty using these links, please navigate around these links, or access the site on a desktop browser.
Skip to the primary content of this page Skip to the footer of this page
Provident Healthcare Partners Provident Healthcare Partners

Q3 2024 Dermatology Update

Provident Healthcare Partners
Skip to the end of the Expertise Menu

Q3 2024 Dermatology Update

The dermatology space continues to see steady transaction volume, albeit at a much slower pace than recent years. The sector has been characterized recently by strategic add-on activity with the majority of deals closed by only a handful of PE-backed consolidators.

PE-backed platforms on their second and third iteration of private equity have been the most active buyers over the last few years. Provident expects that trend to remain and expects that platforms will continue to merge and partner with one another to build scale and regional density in select markets.

Given the trajectory of interest rates, as well as the late stage in the dermatology investment cycle, Provident expects deal volume to experience an upturn over the next few quarters and into 2025.

To print and download the full Dermatology Update report, please click below…

[holo_button icon=”/wp-content/uploads/2024/10/Q3-2024-Dermatology-Newsletter_vP.pdf”” color=”#003561″ target=”blank”]PRINT/DOWNLOAD[/holo_button]